1. Caiazza MC, Lang C, Wade-Martins R (2020) What we can learn from iPSC-derived cellular models of Parkinson’s disease. Prog Brain Res 252:3
2. Johansen KK, Torp SH, Farrer MJ, Gustavsson EK, Aasly JO (2018) A case of Parkinson’s disease with no Lewy body pathology due to a homozygous exon deletion in Parkin. Case Rep Neurol Med 2018:1–4
3. Monzani E, Nicolis S, Dell'Acqua S, Capucciati A, Bacchella C, Zucca FA, Mosharov EV, Sulzer D et al (2019) Dopamine, oxidative stress and protein–quinone modifications in Parkinson’s and other neurodegenerative diseases. Angew Chem Int Ed 58(20):6512–6527
4. Jackson M, Naidoo K, Birch-Machin M (2019) Oxidative stress, metabolism and photoaging—the role of mitochondria. Cutaneous Photoaging 19:105
5. Elmazoglu Z, Kovacikova L, Stefek M, Karasu C (2019) Novel carboxymethylated mercaptotriazinoindole derivatives as potential inhibitors of aldo-keto reductase (akr1b1) ameliorate hyperglycemia mediated and 6-ohda-induced neurotoxicity in pc12 cells: in vitro hyperglycemic Parkinson’s disease model. ispbs–5 proceedings book:47